+ New Watchlist

Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

Eli Lilly

LLYNYSE

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$748.01

-1.91-0.25%

At close: -

$747.07

-0.94-0.13%

After Hours: 7:39 PM EDT

Eli Lilly (LLY) Forecast

News

Earnings Eli Lilly (LLY) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Latest news for Eli Lilly (NYSE:LLY) Stock

Eli Lilly Stock (NYSE: LLY)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, November 21, 2024

Shares Of Hims & Hers Health See Volume; Trad...
Benzinga Newsdesk
Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
Surbhi Jain
Ralph Alvarez Boosts Confidence With $231K Purchase Of Eli Lilly Stock
Benzinga Insights
Eli Lilly Director Trades $233K In Company Stock
Benzinga Insights
Massive Insider Trade At Eli Lilly
Benzinga Insights
Eli Lilly Board Member Trades $229K In Company Stock
Benzinga Insights
Insider Confidence On Display: Juan R Luciano Acquires $234K In Eli Lilly Stock
Benzinga Insights
Eye On Growth: Gabrielle Sulzberger Adds $229K Of Eli Lilly Stock To Portfolio
Benzinga Insights

Wednesday, November 20, 2024

Eli Lilly, Verge Genomics Opt To Develop ALS Drug Candidate
Vandana Singh
Big Pharma's Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System
Vandana Singh
Eli Lilly shares are trading higher after Ver...
Benzinga Newsdesk
Verge Genomics Announced Milestones In Collab...
Benzinga Newsdesk

Tuesday, November 19, 2024

Eli Lilly Elects Jon Moeller As New Member Of...
Benzinga Newsdesk
Eli Lilly Stock Eyes Worst Month Since February 2009: Is It Time To Buy The Dip?
Piero Cingari
Eli Lilly's Investigational Drug Cuts Sticky Cholesterol Levels By Almost 86%
Vandana Singh
Eli Lilly Canada Is Disappointed And Strongly...
Benzinga Newsdesk
Jim Cramer: Coinbase Is A 'Winner,' Suggests Buying This 'Hated' Big Pharma Stock
Avi Kapoor
Eli Lilly Unusual Options Activity
Benzinga Insights

Monday, November 18, 2024

Eli Lilly Says Muvalaplin Met Secondary Endpo...
Benzinga Newsdesk
Lilly's Muvalaplin Reduces Lipoprotein(a) Lev...
Benzinga Newsdesk
Eli Lilly's Zepbound/Mounjaro Shows Cardiovascular Benefits In Patients With Obesity-Related Heart Failure
Vandana Singh
Reported Saturday, Eli Lilly's Tirzepatide Cu...
Benzinga Newsdesk

Sunday, November 17, 2024

Goldman Sachs Economist: Weight-Loss Drugs Could Be Key To US Economic Growth
Bibhu Pattnaik

Friday, November 15, 2024

Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
The Arora Report
Shares of pharmaceutical companies are tradin...
Benzinga Newsdesk
Wolfe Research Initiates Coverage On Eli Lill...
Benzinga Newsdesk
Mounjaro-Maker Eli Lilly Files Lawsuit Against US Agency Over Drug Rebate Program
Pooja Rajkumari

Thursday, November 14, 2024

Donald Trump Jr. Posts On X "Robert F Kennedy...
Benzinga Newsdesk
'Trump Expected To Select Robert F. Kennedy J...
Benzinga Newsdesk
Tiger Global 13F Shows Increased Stake In Uni...
Benzinga Newsdesk
99% Of Mounjaro/Zepbound Patients Remained Diabetes-Free Even At 3 Years, Eli Lilly's Detailed Phase 3 Data Shows
Vandana Singh

Wednesday, November 13, 2024

Eli Lilly Reports Detailed Results From Phase...
Benzinga Newsdesk
Amgen Defends Its Investigational Monthly Weight Loss Injection After Analyst Cites MariTide's Impact on Bone Density
Vandana Singh
Eli Lilly Unusual Options Activity For November 13
Benzinga Insights
Humanitarian Organization Criticizes Eli Lilly, Novo Nordisk And Sanofi Of Having 'Double Standards' For High Insulin Price
Vandana Singh
Jim Cramer Says Eli Lilly's 'Pathetic' Stock Performance Could Get A Breather If Amgen Has Hidden Bone Risk Data After 7% Stock Drop
Kaustubh Bagalkote

Tuesday, November 12, 2024

Tradepulse Power Inflow Alert: Eli Lilly & Company Moves Up Over 13 Points After Signal
Finit
Bristol-Myers Squibb's $14 Billion Potential - Analyst Upgrades Stock
Vandana Singh

Monday, November 11, 2024

Tesla Remains Core For Gary Black Despite Price Cuts, Earnings Drop — Nvidia, Google, Eli Lilly Among Top Performers In Tech Bull's Portfolio
Kaustubh Bagalkote

Friday, November 08, 2024

Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
Vandana Singh

Thursday, November 07, 2024

Compounded Versions Of Weight Loss And Diabetes Drugs Led To Death And Hospitalization, Novo Nordisk Says It Is Aware
Vandana Singh
Market Whales and Their Recent Bets on LLY Options
Benzinga Insights

Tuesday, November 05, 2024

10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Assessing Eli Lilly's Performance Against Competitors In Pharmaceuticals Industry
Benzinga Insights

Monday, November 04, 2024

Eczema Drug Developer Nektar Gains Analyst Confidence With 400% Upside Potential
Vandana Singh
Deutsche Bank Maintains Buy on Eli Lilly, Low...
Benzinga Newsdesk
What's Going On With Hims & Hers Health Stock Monday?
Adam Eckert
As Race To Best 'Miracle' Obesity Drug Heats Up, Ozempic Maker Novo Nordisk Tests New Hybrid Drug That Can Reduce Weight Up To 25%
Pooja Rajkumari

Friday, November 01, 2024

Lilly To Present Results From Phase 3 EMBER-3...
Benzinga Newsdesk
Market Volatility Soars Ahead Of Elections, Tech Earnings Mixed, Strikes And Hurricanes Knock Employment Down: This Week In The Markets
Piero Cingari

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved